Curepharma: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Curepharma
Largest movements
- Cash -€76,095
down €76,095 (-31.4%), from €242,515 to €166,420
mainly Investment in fixed assets (net) (-€72,827) and Net result for the year (-€63,131)
- Intangible fixed assets +€41,667
new in 2025: €41,667
- Tangible fixed assets +€16,510
up €16,510 (+129.6%), from €12,736 to €29,246
of which Plant, machinery and equipment: +€16,510
- Deferred charges and accrued income -€6,544
down €6,544 (-54.6%), from €11,977 to €5,433
- Reserves -€63,131
down €63,131 (-16.9%), from €373,292 to €310,161
of which Distributable reserves: -€63,131
- Debts after one year +€44,567
new in 2025: €44,567
- Current portion of long-term debt +€12,400
new in 2025: €12,400
- Other debts -€10,786
down €10,786 (-14.6%), from €73,983 to €63,197
- Gross operating margin -€40,124
down €40,124 (-46.4%), from €86,468 to €46,344
- Staff costs +€14,237
up €14,237 (+19.2%), from €74,103 to €88,340
- Depreciation +€9,553
up €9,553 (+187.4%), from €5,098 to €14,650
- Financial charges +€2,382
up €2,382 (+85.1%), from €2,799 to €5,181
- Financial income -€2,169
down €2,169 (-62.3%), from €3,480 to €1,311
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €539,965 | €516,103 | -€23,862 | -4.4% |
| Fixed assets | 21/28 | €22,686 | €80,863 | +€58,177 | +256.4% |
| Intangible fixed assets | 21 | - | €41,667 | +€41,667 | |
| Tangible fixed assets | 22/27 | €12,736 | €29,246 | +€16,510 | +129.6% |
| Plant, machinery and equipment | 23 | €12,736 | €29,246 | +€16,510 | +129.6% |
| Furniture and vehicles | 24 | €0 | - | = | |
| Financial fixed assets | 28 | €9,950 | €9,950 | = | 0.0% |
| Current assets | 29/58 | €517,279 | €435,241 | -€82,039 | -15.9% |
| Stocks and contracts in progress | 3 | €193,146 | €188,638 | -€4,509 | -2.3% |
| Stocks | 30/36 | €193,146 | €188,638 | -€4,509 | -2.3% |
| Amounts receivable within one year | 40/41 | €69,641 | €74,750 | +€5,109 | +7.3% |
| Trade receivables | 40 | €61,891 | €61,274 | -€618 | -1.0% |
| Other amounts receivable | 41 | €7,750 | €13,476 | +€5,727 | +73.9% |
| Cash at bank and in hand | 54/58 | €242,515 | €166,420 | -€76,095 | -31.4% |
| Deferred charges and accrued income | 490/1 | €11,977 | €5,433 | -€6,544 | -54.6% |
| Total equity and liabilities | 10/49 | €539,965 | €516,103 | -€23,862 | -4.4% |
| Equity | 10/15 | €418,292 | €355,161 | -€63,131 | -15.1% |
| Contributions | 10/11 | €45,000 | €45,000 | = | 0.0% |
| Reserves | 13 | €373,292 | €310,161 | -€63,131 | -16.9% |
| Tax-exempt reserves | 132 | €5,949 | €5,949 | = | 0.0% |
| Distributable reserves | 133 | €367,343 | €304,212 | -€63,131 | -17.2% |
| Profit (loss) carried forward | 14 | €0 | - | = | |
| Amounts payable | 17/49 | €121,673 | €160,942 | +€39,269 | +32.3% |
| Amounts payable after more than one year | 17 | - | €44,567 | +€44,567 | |
| Financial debts | 170/4 | - | €44,567 | +€44,567 | |
| Amounts payable within one year | 42/48 | €119,966 | €116,374 | -€3,592 | -3.0% |
| Current portion of amounts payable after more than one year | 42 | - | €12,400 | +€12,400 | |
| Trade debts | 44 | €35,982 | €31,187 | -€4,795 | -13.3% |
| Suppliers | 440/4 | €35,982 | €31,187 | -€4,795 | -13.3% |
| Taxes, remuneration and social security | 45 | €10,001 | €9,590 | -€411 | -4.1% |
| Taxes | 450/3 | €1,668 | €0 | -€1,668 | -100.0% |
| Remuneration and social security | 454/9 | €8,333 | €9,590 | +€1,257 | +15.1% |
| Other amounts payable | 47/48 | €73,983 | €63,197 | -€10,786 | -14.6% |
| Accrued charges and deferred income | 492/3 | €1,707 | €0 | -€1,707 | -100.0% |
| Remuneration, social security and pensions | 62 | €74,103 | €88,340 | +€14,237 | +19.2% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €5,098 | €14,650 | +€9,553 | +187.4% |
| Other operating charges | 640/8 | €698 | €2,615 | +€1,916 | +274.4% |
| Non-recurring operating charges | 66A | €403 | €0 | -€403 | -100.0% |
| Gross operating margin | 9900 | €86,468 | €46,344 | -€40,124 | -46.4% |
| Operating profit (loss) | 9901 | €6,166 | -€59,261 | -€65,427 | |
| Financial income | 75/76B | €3,480 | €1,311 | -€2,169 | -62.3% |
| Recurring financial income | 75 | €3,480 | €1,311 | -€2,169 | -62.3% |
| Financial charges | 65/66B | €2,799 | €5,181 | +€2,382 | +85.1% |
| Recurring financial charges | 65 | €2,799 | €5,181 | +€2,382 | +85.1% |
| Profit (loss) for the period before taxes | 9903 | €6,847 | -€63,131 | -€69,978 | |
| Income taxes | 67/77 | €2,084 | €0 | -€2,084 | -100.0% |
| Profit (loss) for the period | 9904 | €4,763 | -€63,131 | -€67,893 | |
| Profit (loss) for the period to be appropriated | 9905 | €4,763 | -€63,131 | -€67,893 |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 5 October 2026 via checked.be.